Ron had a sudden alert when he learned he had one of the rarest of diseases. Listen to this conversation to learn how he managed diagnosis, treatment, and survivorship in this episode.

Find out the relationship between Hepatitis and Aplastic Anemia in this episode with Dr. Roma Rajput.

AAMDSIF Director of Patient Programs, Leigh Clark, asks Brian about his life before diagnosis, during "watch and wait," through transplant, to now. Listen here to his myelodysplastic syndromes, or MDS, patient journey.

AAMDSIF Director of Patient Services, Leigh Clark, asks Mario about his journey with Aplastic Anemia.  The conversation includes treatment and survivorship.
 

Evan biked daily. He had no symptoms.  The diagnosis was fast, but surprising. Evan shares his remarkable story in this episode.

What does this FDA approval mean for patients with PNH?  Find out how this oral medication, Fabhalta, could replace one of the infusion treatments in this interview with Dr. Bart Scott.

Here is a discussion about recent FDA approval of Tibsovo for Relapsed/Refractory MDS with Dr. Amir Fathi, who is an Associate Professor of Medicine at Harvard Medical School and the Director of the Leukemia Program at Massachusetts General Hospital.
 

This episode focuses on the US Food and Drug Administration expanded access approval of luspatercept or Reblozyl with Dr. Guillermo Garcia-Manero, Chief of the Section of MDS in the Department of Leukemia at MD Anderson Cancer Center in Houston.